Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
Deloitte
QuintilesIMS
Cipla
Argus Health
Fuji
Colorcon

Generated: September 19, 2018

DrugPatentWatch Database Preview

TRANDATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for TRANDATE
Pharmacology for TRANDATE
Synonyms for TRANDATE
(non-labelled)Labetalol-d6
2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide
2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide
2-Hydroxy-5-(1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl)benzamide
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzene-1-carboximidic acid
3-Carboxamido-4-hydroxy-.alpha.-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
36894-69-6
5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
894L696
AB00053659
AB00053659_13
AC-18747
AC1L1GW8
ACN-052896
AH 5158
AH-5158
AK116436
AKOS015908406
Albetol
Amipress (Salt/Mix)
API0026318
AX8135748
BC214322
BDBM25758
Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-
Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-
BENZAMIDE,2-HYDROXY-5-[(1R)-1-HYDROXY-2-[[(1S)-1-METHYL-3-PHENYLPROPYL]AMINO]ETHYL]-,REL-
BPBio1_000170
BRD-A07440155-003-05-6
BSPBio_000154
BSPBio_003142
C-19934
C07063
CCG-204772
CHEBI:6343
CHEMBL429
D08106
D0A8XN
DB00598
DivK1c_000474
DTXSID2023191
EC 253-258-3
EINECS 253-258-3
FT-0630598
GTPL7207
HSDB 6537
Ibidomide
IDI1_000474
KB-230863
KBio1_000474
KBio2_002087
KBio2_004655
KBio2_007223
KBio3_002642
KBioGR_000727
KBioSS_002087
KS-00000GGT
L001344
labetalol
Labetalol (INN)
Labetalol [INN:BAN]
Labetalol hydrochloride (Salt/Mix)
Labetalolum
Labetalolum [INN-Latin]
Labetolol
Lopac0_000687
LS-26936
MCULE-6427232261
MFCD00242941
MolPort-003-898-140
NCGC00015595-03
NCGC00015595-04
NCGC00015595-06
NCGC00015595-07
NCGC00089800-02
NINDS_000474
Normodyne
Normodyne (Salt/Mix)
Normodyne (TN)
NORMOZIDE
OR067997
OR263607
OR333390
Prestwick0_000277
Prestwick1_000277
Prestwick2_000277
Prestwick3_000277
Q-201273
R5H8897N95
SBB067266
SBI-0050665.P003
SC-15826
ScH 15719W
Sch-19927
SCHEMBL4582
SGUAFYQXFOLMHL-UHFFFAOYSA-N
SPBio_000905
SPBio_002373
Spectrum_001607
Spectrum2_000863
Spectrum3_001581
Spectrum4_000184
Spectrum5_001010
TL8002725
Trandate (Salt/Mix)
Trandate (TN)
U685
UNII-R5H8897N95

US Patents and Regulatory Information for TRANDATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd TRANDATE labetalol hydrochloride INJECTABLE;INJECTION 019425-001 Dec 31, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline TRANDATE HCT hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019174-002 Apr 10, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline TRANDATE HCT hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019174-003 Apr 10, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for TRANDATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd TRANDATE labetalol hydrochloride INJECTABLE;INJECTION 019425-001 Dec 31, 1985 ➤ Sign Up ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 ➤ Sign Up ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 ➤ Sign Up ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 ➤ Sign Up ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-004 Aug 1, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
Deloitte
QuintilesIMS
Cipla
Argus Health
Fuji
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.